glp 1 and graves disease Graves' GLP-1 Weight Loss: Safety Guide GLP-1-based therapies for diabetes, obesity
Description
PlexusDx explains medical eligibility and personalized treatment options
Support weight loss and metabolism*
IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits
In addition to their glycemic effects, DPP-4 inhibitors have the potential to decrease bone resorption, increase bone formation, and reduce the incidence of osteoporosis and fractures
No judgment
In those already addicted, the GLP-1 drugs were linked to lower risks of hospitalization, overdose and death, according to a study.
